Biologic Therapy for Osteoarthritis in Dallas, TX

osteoarthritis biologic therapy for a city of 1M+ — without a fake storefront

Two files matter before you open a box of osteoarthritis biologic therapy in Dallas: (1) CDC PLACES (2023, crude) estimates 12.4% of adults in Dallas have diagnosed diabetes — 0.4 points above the U.S. 12% figure. (2) Texas Part B wound biologics are reviewed by Novitas Solutions under JH, shared with AR, CO, LA, MS, NM, OK. We help with the second file. We do not pretend to be a Dallas storefront.

If you already “have a vendor”

• Adult arthritis here is 18.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 22.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Texas.
• In a city of 1M+, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Dallas street address.
• Skin-substitute and CTP coverage has been rewritten multiple times at the MAC level. Texas practices billing Novitas Solutions need current LCD/article IDs on the claim, not a distributor slogan about “advanced wound care.”

Why we will not invent a Dallas diabetes rate

22.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 1M+ with 1,304,379 residents will still mix those payers. CDC PLACES (2023, crude) estimates 12.4% of adults in Dallas have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.

Do this before you expand SKUs